CTOs on the Move

Neuralstem

www.neuralstem.com

 
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.neuralstem.com
  • 20271 Goldenrod Lane 2nd Floor
    Germantown, MD USA 20876
  • Phone: 301.366.4960

Executives

Name Title Contact Details

Similar Companies

Ampio Pharmaceuticals

Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates.  These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending.  Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™.  The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.  Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema.  Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.

Laurel Health System

Laurel Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Laurel Health System is based in Wellsboro, PA. You can find more information on Laurel Health System at www.laurelhs.org

BBK Worldwide

BBK Worldwide is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fungal Free Nails

Fungal Free Nails is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Exthera Medical

Exthera Medical is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.